KRAS and colorectal cancer: In parallel, BRAF- or KRAS-mutated colorectal cancers have been shown to exhibit distinct microbial profiles, notably with enrichment in Fusobacteria and Firmicutes, pointing to a broader association between oncogenic mutations and gut microbiota composition19,20.